| Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. | breast, |
| Oncoprotein 18 levels and phosphorylation mediate megakaryocyte polyploidization in human erythroleukemia cells. | leukemia, |
| Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. | lung, |
| Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia. | leukemia, |
| PDEF may inhibit prostate cancer progression by transcriptional downregulation of oncogenic STMN expression. | prostate, |
| An underlying prognosis predictor of hepatocellular carcinoma: Oncoprotein 18. | liver, |
| Results demonstrates that STMN1 silencing arrests tumor-disseminative cascades by inhibiting multiple metastatic drivers, and repressing oncogenic and mesenchymal transcription in colorectal cancer cells. | colorectal, |
| Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas. | lymphoma, |
| Expression of oncoprotein 18 in human leukemias and lymphomas. | lymphoma,leukemia, |
| Identification of the pro-oncogene stathmin/op18 mRNA in the brain of mitochondrial Mn-superoxide dismutase-deficient mice by a modified differential display PCR. | brain, |
| Mutations of oncoprotein 18/stathmin identify tubulin-directed regulatory activities distinct from tubulin association. | None |
| Decreasing oncoprotein 18/stathmin levels reduces microtubule catastrophes and increases microtubule polymer in vivo. | None |
| Tumor necrosis factor-induced microtubule stabilization mediated by hyperphosphorylated oncoprotein 18 promotes cell death. | None |
| The oncoprotein 18/stathmin family of microtubule destabilizers. | None |
| Stathmin/oncoprotein 18, a microtubule regulatory protein, is required for survival of both normal and cancer cell lines lacking the tumor suppressor, p53. | None |
| c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18. | None |
| In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoprotein. | None |
| Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma. | None |
| G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems. | None |
| Serine 16 of oncoprotein 18 is a major cytosolic target for the Ca2+/calmodulin-dependent kinase-Gr. | None |